Below
is an edited version of the webinar
I presented through the Triple-Negative
Breast Cancer Foundation October 16, 2012. You can still get the actual webinar
on the Foundation’s site. It was based
on questions sent in from women with TNBC.
I
was diagnosed with hormone negative breast cancer in 2006, and I've been
studying this disease since then, reading research papers, interviewing experts
and writing about TNBC, cancer in general and other broad health topics such as
nutrition and exercise.
As a health journalist, I've been able
to talk with oncologists, psychologists, dieticians, exercise specialists and
researchers on everything from chemo brain to the benefits of acai. I have learned a great
deal from them.
More important, I have visited with
hundreds of women with TNBC through this blog.
So, I know what it is like to walk this road, and I think I understand
at least some of what you are going through.
It is this last perspective, yours, that
I keep foremost in my mind.
I'm not a doctor. I'm one of you.
Now to the questions:
Q.
How do I manage the stress of TNBC plus family and job strain?
Stress hits all of us at one time or
another after diagnosis, during treatment and as we face life after cancer. I
could talk about this all month and not get it all in.
So, I will briefly discuss three areas -
juggling everyday life, finding support and managing worries.
Our lives keep going even when we get
sick. The kids need to get to school,
the toilets need cleaning, we need to pay the--we need to work to pay for all
of this. And some of us have other
family members with health issues to worry about, as well.
This is, in fact, overwhelming. So, you
have to ask for help, more than once, of many different people.
Recognize that some people are as
helpful as the day is long, and some simply aren't, and most are in
between. So, if somebody disappoints
you, don't think that everybody will do the same thing. Ask somebody else.
And
be specific. You will get many people saying, let me know
if you need help. Let them know with
details. Can you pick Lily up after
preschool tomorrow? I hate going to
chemo alone. Would you come with
me? It will give us a good chance to
chat.
Find
a supportive friend
with whom you can cry, fret, vent and just emotionally exhale or laugh a lot, laughter is such good therapy, or
discuss this disease with them and help find clarification in your own mind.
We've all made good friends online who
can send us virtual hugs. I do it all
the time, so let me know if you need one.
But, it's good to get an in person hug, as well.
Now,
to worry. I believe there is stress that is
specific to TNBC, and there is some research to support that. In a survey of 989 women with breast cancer,
those with estrogen negative breast cancer reported the highest level of stress
as did Black and Latino women.
But, this leads us to a chicken or egg
question. Did the stress lead to the
cancer or did the cancer lead to the stress?
The survey did not test for this, but
the research does indicate that stress may be more specifically associated with
TNBC than with other breast cancer subtypes.
And this is tied to something that
bothers me every time I read about this disease in a research paper or on the
news because we often use these words lethal, deadly, especially aggressive.
TNBC-related stress then can be
especially heightened by not having a plain old breast cancer but one that is
characterized with doctors, researchers and writers as especially deadly—as
though we thought there were other kinds.
Look at this recent post on my Facebook
page in which I ranted about my frustration with journalists and researchers
who use these terms and imply that the disease is automatically a killer. I got
a surprising result. My TNBC women
popped up immediately with responses.
Women agreed that hearing those words adds to their stress.
Some typical responses:
“Every time I read those phrases, my heart skips a beat."
“I do get very depressed and scared when I read terms such as particularly deadly.”
“Gets me every time, makes me get a lump in my throat.”
“Every time I read those phrases, my heart skips a beat."
“I do get very depressed and scared when I read terms such as particularly deadly.”
“Gets me every time, makes me get a lump in my throat.”
And because we are dealing with an
especially mean disease, we worry that
we have to do everything, everything, everything we can to combat it—
become organic vegetarians, and get two hours of exercise a day, and meditate
and read medical books and take every vitamin and supplement known to humankind
and paint the kitchen.
Okay, I exaggerate, a little. But I have noticed that women with this disease
can be extremely hard on themselves by trying to take on the world of healthy
eating, living, thinking and being all at once, all fabulous goals, but you can't ever do everything at once,
especially when you have other responsibilities to manage, as we all do. So,
don't try to do and be everything.
Look
for balance.
We will talk about diet and physical
activity in a minute, but in all things, go for moderation and balance. Don't try to change your lifestyle on a
dime. Go slowly and implement changes
bit by bit.
Cut out some sugary goodies and
processed foods like doughnuts, colas, cookies, potato chips and French
fries. Those don't do anybody any
good. But, leave yourself some
treats. Don't try to become the Mother
Teresa of health foods over night.
If an ice cream cone or chocolate malt
gets you through the day right now, that is just fine. And you might need to get through treatment first
before you go for significant lifestyle changes. One step at a time.
Another root of some of our stress, I
believe, is the thought that we caused our cancer. We didn't eat well enough, we drank too much,
exercised too little, took on too much work.
Okay, that was me. But, seriously, one of our first thoughts
when we are diagnosed is what did I do to cause this? That's a decent question to ask in terms of
modifying your behavior to reduce your risk of recurrence, but don't beat yourself up for not having lived
a perfect life up to this point. And
don’t try to be perfect now. Phew, talk about stress.
You
did not cause your cancer.
You can reduce some of your stress by
getting offline. Shut down the computer and go do something else. Yes, this seems
ironic coming from a person talking to you online. But, consider limiting your computer
time. Set an alarm to go off in a half
hour, and make that your stopping point. You can spend hours sucked into the
ether of the internet, and it is just not a good use of your time, your mind or
especially your soul.
Plus, it is easy to soak up other
people's stress. When I was going
through treatment, I could physically feel my stress building online because I
was reading about this person's TNBC recurrence, that person's side effects and
the death of a favorite online friend.Worries that never before had occurred to
me suddenly loomed as real possibilities.
I shut off the computer.
Take the time you'd use online and give
yourself a break. Brew a cup of tea, and find a pleasant
place to drink it, outside if possible, or inside with some music. Do nothing but enjoy the tea, and take deep
breaths. When the stress intrudes, push
it away with a deep cleansing breath. I once posted a simple note on my blog,
breathe in, breathe out, and think of something beautiful. I was astounded at the emails I got on that
one. Apparently, we need to be reminded
to breathe. Try it now. Breathe in,
breathe out, breathe in, breathe out.
Ah, doesn't that feel good? And the thing about a tea break is it only
needs to last as long as it takes you to drink the tea. So, it does not require a huge planning or a
time commitment, but it gives you an important breather, literally.
Just
a little activity also will help reduce stress.
The activity itself calms our bodies, but going off and doing something
also reboots our mind into thinking about something other than taxanes versus anthracyclines.
And research on breast cancer patients
has shown that going outdoors helped clear their minds and helped them think
better.
Yoga is an especially helpful stress
reliever, helping us sleep better and relieving fatigue. Yoga uses deep breathing and stretching
techniques that can be low impact and easy to do when you're lacking energy. I
do a 20-minute morning routine that calms me like almost nothing can, and it
takes less time to do than follow a new thread on a message board.
And, finally, don't turn to alcohol to reduce stress.
Alcohol may calm us for a minute, but it causes a host of problems
later on including increasing our cancer risk.
It leads to poorer sleep and nervousness when the initial effects wear
out. So, it can actually increase our stress.
Again, moderation. A glass of wine
occasionally is a nice break. It should
not, however, become a habit or a necessity.
Q. How survivable is TNBC? What Is the risk of recurrence?
One of the top research questions that
gets people to my blog is: Can you
survive triple negative breast cancer. That breaks my heart, as I imagine a woman
sitting alone at her computer, looking to the internet for help, terrified she
is going to die.
And some version of this concern was
included in your questions. This is the
bottom line, isn't it? Can we survive?
The short answer is, yes, this disease is survivable. And most women do survive it. This is a disease to take seriously, and it's
important to follow the treatment regimen your healthcare team suggests. But, the majority of women with non-metastatic
TNBC survive it and go on to live full lives.
There are now more than 80 clinical
trials focused on TNBC, many of them on metastatic disease. So, I
am extremely hopeful that we'll find successful treatments for this disease
even at its most advanced stages.
We'll look at the numbers soon, and
we'll deal with survival and risk of recurrence together.
First, some numbers on statistics for
TNBC: In general, survival rates decrease with larger tumors and those with
affected lymph nodes. But, after three
years, the chance of recurrence of TNBC drops significantly. And after five years, the risk of recurrence
of TNBC is actually lower than for other forms of breast cancer.
But, statistics give us a sense of one
group of people with specific traits and treatments. They do not translate directly to everybody.
The more we know about the genetic
makeup of breast cancer, especially of TNBC, the more we realize that our
cancers may be as unique as our DNA. So the
only real statistic that holds true is our own.
It wasn't until 2005 that researchers
used the term triple negative breast
cancer, essentially naming a new subset of cancer. This was the result of the discovery of the
human epidermal growth factor receptor HER2/neu in the 1980s.
Studies on HER2/neu led researchers to a
web of subsets within subsets, including TNBC and HER2 positive breast
cancer. And this refined our
understanding of breast cancer as a whole, demonstrating that this is a complex
disease fueled by a multitude of factors.
And current research on the genetic
makeup of breast cancer will likely lead us to more and more subsets of TNBC so
that we might soon be talking about quadruple or quintuple or sextuple negative
breast cancer.
Because TNBC is a relatively new
disease, we lack long-term studies on it.
Much of the research I will present here will be on estrogen negative
disease or estrogen negative and progesterone negative. Many of these studies either did not have
HER2/neu information or did not use that data, because at the time, they did
not realize its significance.
I'm sure you all followed the news a few
months ago when researchers with the Cancer
Genome Atlas Program announced that basal-like breast cancers, many
of which are triple negative, bear a molecular similarity to ovarian
cancers. In fact, basal-like breast
cancers are more like ovarian cancers, they said, than like hormone positive
breast cancer.
Many of the reports I read about this
research, though, assumed that all basal-like tumors are triple negative. TNBC is not synonymous with basal-like. Basal-like tumors are one subset of TNBC.
Some of the researchers on the genome
project have said that basal-like cancers might be a different disease all
together from other forms of breast cancer.
Okay.
So, survivability. I would like
to briefly show you what the research says about survival in relation to common
treatments for TNBC, adjuvant chemotherapy, which is done after surgery,
neo-adjuvant chemotherapy, which is done before surgery, lumpectomy and
mastectomy.
My goal here is to provide a snapshot of
research with a goal of demonstrating survival rates
A large body of research demonstrates
that chemotherapy is especially
effective against hormone negative breast cancer, and newer forms of chemo are
better than older forms. One
groundbreaking study demonstrated that advances since the 1980s in chemotherapy
after surgery—adjuvant therapy—have significantly reduced the risk of death in
estrogen negative patients with affected lymph nodes.
Newer
chemo regimens yielded a five-year overall survival rate of 83 percent. This
compared to 66 percent for earlier treatment.
Newer regimens of chemotherapy that were
studied were high doses of Cytoxan and Adriamycin every two weeks plus Taxol. Older forms were low doses of Cytoxan and Adriamycin
plus Fluorouracil every three weeks.
Another study on adjuvant therapy for
patients with stages I, II, and III, done at the MD Andersen Cancer Clinic and
published in 2008, showed a surprisingly low recurrence rate for hormone
negative breast cancer. Nearly 93 percent of the women with stage one had
no recurrence within five years, and nearly 89 percent had no recurrence after
ten years.
Eighty-nine
percent of those with stage two had no recurrence within five years. And 87 percent of those with stage three had
no recurrence within five years. In this study, women with hormone negative
breast cancer actually did better than those with hormone positive.
What about neo-adjuvant chemo for TNBC,
chemo before surgery? In another study
from MD Andersen, women with a complete
pathological response, no sign of cancer after chemo, had a three-year overall
survival rate of 94 percent. And
even those without a complete pathological response had encouraging overall
survival rates: 68 percent. Chemotherapy
regimens varied for those studied include and included Fluorouracil,
Adriamycin, Cytoxan, Epirubicin, Paclitaxel and Docetaxel.
The question of which regimen is best
for you is for a healthcare provider to answer.
There are some standard chemotherapy regimens for TNBC, and your
healthcare team will help determine which works best in your case.
Some of the most regularly prescribed
regimens for treatment of hormone negative breast cancer are AC, which is
Adriamycin and Cytoxan, an anthracycline and an alkylating agent. This had one been the gold standard for
breast cancers that had not spread to the lymph nodes. This is the therapy I had, four treatments
every two weeks of Adriamycin and
Cytoxan.
Some cancer centers are replacing it
with therapies that replace the Adriamycin with a taxane, and that's TC, which
is a taxane plus an alkylating agent, usually Cytoxan, which can be less toxic
than Adriamycin.
ACT is an anthracycline and an alkylating
agent plus a taxane. The anthracycline and alkylating agent,
usually Adriamycin and Cytoxan, are given first, followed by a taxane, usually
Paclitaxel or Docetaxel. This is used for
node-positive or metastatic breast cancer.
TAC is an anthracycline and an alkylating
agent plus a taxane, usually administered concurrently. This is usually for aggressive breast cancer,
large locally advanced or metastatic.
And, finally, CMF, which is a
combination of Cytoxan, Methotrexate and Fluorouracil. This was one of the
earliest drug regimens, but it is being replaced by more modern
treatments. However, it may be still
used for women who cannot tolerate newer chemo drugs.
And research will continue to lead us to
new treatments. Because of the
similarities between ovarian cancer and basal-like breast cancer, current
treatments for ovarian cancer, which are a little less toxic, might work for
TNBC. These typically combine a platinum
agent such as Carboplatin or Cisplatin with a taxane such as Paclitaxel or
Docetaxel.
Now, to surgery:
A lumpectomy with clear margins plus
radiation is as successful in reducing risk of recurrence as a mastectomy for
tumors under four centimeters according to landmark research published in the New England Journal of Medicine that
followed women 20 years after surgery.
Note that tumors four centimeters or larger would necessitate a
mastectomy, and those without clear margins will require additional surgery.
In more current research, which analyzed
tumors by receptor status, early stage hormone negative tumors actually
responded better to a lumpectomy plus radiation than to a mastectomy.
This study should be considered just the
beginning of the discussion, though, not the final conclusion. But, it does indicate that lumpectomy plus
radiation may be at least equal to mastectomy for early stage tumors. And clear margins are especially important
for patients with triple negative breast cancer.
Q.
What about long-term chemo side effects?
We've all been following the news of
Robin Roberts’ diagnosis of MDS after successful treatment for TNBC. As Robin's fans, we wish her the best and
keep her in our prayers and were heartened by her response to bone marrow
treatment.
We also understandably worry about the
long-term effects of our own treatment.
Could this happen to us?
The fact is that chemotherapy comes with
some risk of secondary cancers—cancers that are actually precipitated by the
chemotherapy treatment, but these risks are low. And other factors such as genetics and family
history play a role, as well.
Which drugs are involved? In the specific case of MDS, some common
drugs for TNBC treatment may be implicated, especially Adriamycin and
Cisplatin, and to a lesser extent, Cytoxan.
The risk is greater for higher doses, longer treatment times and dose
dense regimens.
Other long-term side effects include a
low risk of cardio dysfunction with Adriamycin and Avastin and osteoporosis and
bone loss related to Cytoxan. And this
is usually because Cytoxan can cause early menopause.
But,
effects such as MDS are really not likely.
They are a slight possibility.
They're not a probability. They
are a possibility.
When somebody with Robin's popularity
has a side effect, it is a big news story, so we get intense multimedia
coverage about the issue, which makes it seem far more common than it is. In fact, some media analysts have criticized
the coverage of Robin's MDS because it presents a false picture of reality.
The fact is that the risk is low. Researchers are constantly improving chemo
drugs, and these drugs save our lives.
And we can improve our overall response
to chemo with exercise that builds our hearts and bones and a healthy diet that
strengthens our immune system. And make
sure you have enough calcium, especially from natural sources such as milk and
cheese.]
So, where can I get more information on
chemo drugs? This is an awful lot to
digest.
Some sites I like:
Chemocare (From The Cleveland
Clinic Cancer Center in affiliation with Scott Hamilton)
Drugs. com (From Wolters Kluwer Health, American Society of
Health-System Pharmacists, Cerner Multum, and Thomson Reuters Micromedex.)
MedicineNet (Affiliated with WebMD)
MedlinePlus (From
the National Institutes of Health and the National Library of Medicine)
Q. Does a low-fat diet really help? Is there clinical evidence to prove that?
The evidence here may seem contradictory
with major studies coming to different conclusions. But, to me, arguing about this study or that
gets us nowhere.
The fact is that high levels of dietary
fat are linked to a multitude of diseases such as diabetes, heart disease and
other forms of cancer. It can lead to
weight gain, which can increase our health risk for other problems such as
arthritis. So, cutting fat is just good
for our overall health.
It is not a magic bullet, however, that
will absolutely fend off triple negative.
There is no such thing.
But, a low-fat diet is one fairly easy
step toward overall good health, and a healthy body can help you fight disease.
We do know that a low-fat diet results
in weight loss, which was demonstrated in the Women's
Intervention Nutrition Study, which may be the study that motivated
this question. In it, post-menopausal
women with early stage estrogen negative cancer on a low fat diet of 32 grams
of fat daily lost weight and reduced their risk of recurrence by 42 percent
compared to those who were not on a low fat diet.
But, what we don't know is if the risk
of recurrence was reduced specifically because of the low fat diet or if it was
because of the weight loss that the diet brought. And this research studied estrogen negative
patients, not specifically TNBC patients.
So, it might need to be replicated with women with TNBC.
And in fact, the Women's
Healthy Eating and Living Study found that reducing dietary fat
alone did not reduce risk of recurrence or death. But, an overall healthy diet high in fruits
and vegetables, five servings a day, did provide a benefit. Again, we don't know if this benefit came
because of the diet itself, the weight loss it brought or some other
combination of factors.
So, my advice is to not rely on just one
element of a healthy diet such as fat. Look at your overall eating habits. A healthy diet should be high in fruits and
vegetables, five to seven servings a day, whole grains, beans and nuts, and it
should be low in saturated and trans fats.
But, in terms of fats, not all fat is
created equal. So, it's important to pay
attention to the type you include in your diet.
Saturated fats are “bad” fats. These are in lard and butter and cheese. Trans fats— those in vegetable shortening and
some margarines, packaged cookies, fries, chips—are also “bad.” We should avoid “bad” fats as much as we can.
“Good”
fats, however, should have a place in our diet.
These include mono unsaturated—
in olive oil, canola oil, nuts and avocados—and poly unsaturated fats—omega 3
fats that are in fish and plus walnuts, flax seeds, canola and soy bean oils
and the omega 6 fats that are in soybeans, safflower, corn oils, nuts and
seeds. And I'd emphasize mostly the nuts
and seeds parts of that.
But, recognize that even good fats pack
on the calories. So, go with moderation
there, as well.
Q. Has exercise been clinically proven to reduce our
risk of TNBC?
Exercise has consistently been
associated with a reduced risk of recurrence of all forms of breast cancer,
including triple negative. And like a
healthy diet, it helps our overall health and builds our defenses against a
host of other diseases from diabetes to Alzheimer's. Plus, exercise just helps clear your mind and
boost your energy, which are benefits enough in my mind.
Again, though, we don't know whether it
is the exercise itself that is the mechanism or the weight loss it brings or a
combined influence of exercise and diet or some other factors.
The entire area is getting the research
it needs, and we may ultimately have some clearer answers.
But, let's look at some of the research
that we've had in the past. Premenopausal women who exercise the most had the
lowest incidence of both triple negative and hormone positive breast cancer
according to research published in 2011.
But, consider this: The reduced risk was
tied to a low body mass index. Those
least at risk had a BMI of less than 23.75, and that is about average—23 to 25
is about average. Those most at risk had
a BMI over 31, which is considered the beginning of obesity.
So, again, was the reduced risk linked
to the exercise or to the weight loss?
We just don't know.
And how much exercise is enough for you
to lead you to that weight loss? Whatever
you can handle.
According to the California Teachers
Study, long-term exercise, both strenuous, like running, and moderate, which
includes a brisk walk, was associated with the reduced risk of estrogen
negative breast cancer. The strongest influence comes from exercise
from more than four hours a week continued for more than a year.
Okay.
How can I start exercising when I feel awful? I completely understand this business of
feeling awful. If you are in the midst of treatment, go slowly for now: a short
walk followed by a longer walk, then a longer one, whatever you can
handle. Exercise can eventually become a
given in your daily schedule if you are physically up to it.
And weight loss experts prefer to talk
about physical activity rather than exercise because it is more inclusive and
less overwhelming. It includes
everything from mowing the lawn to jogging.
And here's how to make it happen. First, do
what you enjoy. Don't decide that
you will jog every morning if you truly hate to run. Walk instead.
And look for scenery that can help divert your attention.
If you are not up to rigorous walks, do
what you can. Exercise early and often. If
at all possible, go for that walk first thing in the morning before the excuses
of the day build up and before you're too tired to care.
If that doesn't work, add a little physical activity to your day
whenever you can, maybe a walk after breakfast or playing with the kids or
grandkids in the afternoon.
Find
a support system. Look for an exercise buddy. Time goes by so much quicker if you are
jabbering with a friend. Plus, you're
more likely to show up for that evening walk if somebody's waiting for you.
And finally, get a dog. When Bowzer needs
a walk, that's that.
Q.
How do I find a TNBC expert to treat me?
A good healthcare team is essential, one that is informed and committed and pays attention to your specific case and your needs.
A good healthcare team is essential, one that is informed and committed and pays attention to your specific case and your needs.
This should include an oncologist,
oncology nurses, the radiation oncology staff and a nurse navigator or advocate
to help you process this all. A
dietician or nutritionist would also be especially helpful.
A good team does not need to be TNBC
specific. A qualified cancer specialist
should be aware of the best treatments for TNBC.
In most cases, you will find the most comprehensive
care in a clinic that is dedicated to cancer care, which can be especially
difficult for women in rural areas. But,
this is one case in which home grown may not be the best. A hospital associated with a university
medical school can help assure that your team is up to date with new research.
U.S.
News consistently rates the best cancer centers. They give you the top 50, but then they also
offer numerical ratings of about 900 other hospitals in the United States. I don't think we'll be surprised with the top
five: MD Andersen, Memorial Sloan Kettering, Johns Hopkins, the Mayo Clinic and
Dana Farber, Brigham and Women's Cancer Center.
But this does not mean that your cancer
center close to you cannot do a good job.
Just do a little bit of research and make sure you've got that good
healthcare team.
Q.
Can you talk about the fact that research on cancer prevention is not helpful
to those of us who are already have the disease?
You know, actually, I think it is.
I look at cancer prevention stats as
similar to stats on reducing risk of recurrence. If researchers have an idea of what might
prevent cancer to begin with, I see that as hope for preventing a recurrence.
Q.
What are some recommended websites for keeping up to date on the latest
treatment news for TNBC that are not overly scientific nor overly simplistic?
These are some of my favorite sites:
The Triple-Negative Breast Cancer Foundation is focused
entirely on TNBC, with research data, background information and perspective,
special events, presentations, and message boards.
Living
Beyond Breast Cancer regularly sponsors webcasts on triple-negative,
available as transcripts and podcasts.
Breastcancer. org offers
broad-based information on all forms of breast cancer, with data on diagnosis
and treatment.
Positives About Negative is my blog,
focused on triple-negative and other forms of triple-negative breast cancer.
The National Comprehensive Cancer Network
provides guidelines for treatment of women with breast cancer based upon best
available evidence. Updated as new information becomes available.
The National Cancer Institute presents
comprehensive information about all kinds of cancers and also lists available
clinical trials.
The
San Antonio Breast Cancer Symposium http://www.sabcs.org is an
annual international forum, with the latest research from clinical trials.
Abstracts are available on their website.
There is much more I could
add, but I hope I have at least addressed your biggest questions. I will provide the Foundation with all the
links I have included in this presentation, and I have hope--hope I have helped you at least a little. And I wish you all well. I have tried to deal with many of these
issues in my book, and I hope it helps.
Now, I will end with a virtual hug. Take care, and thank you for listening. And thanks to the Triple Negative Breast Cancer Foundation for providing me with this forum.
(Find the full webinar here.)
Please consider a donation to Positives About Negative to keep this site going. This work is entirely supported by readers. Just click on the Donate button in the right of the page. Thank you!
Read more about TNBC in my book, Surviving Triple-Negative Breast Cancer.
STUDIES CITED:
Cimprich, Bernadine and Ronis, David. “An
Environmental Intervention to Restore Attention in Women With Newly Diagnosed
Breast Cancer.” Cancer Nursing, Vol.
26, No. 4 (2003).
Berry, Donald A., et al. “Estrogen-Receptor Status and
Outcomes of Modern Chemotherapy for Patients with Node-Positive Breast Cancer.”
JAMA : The Journal of the American
Medical Association, vol. 295, no. 14, 1658-1667
(2006).
Brewster, A. M., et al. “Residual Risk of Breast Cancer Recurrence
5 Years After Adjuvant Therapy.” Journal
of the National Cancer Institute, 100(16):1179-1183
(2008).
Chlebowski, Rowan T., et al. “Dietary Fat Reduction and
Breast Cancer Outcome: Interim Efficacy Results From the Women's Intervention
Nutrition Study.” Journal of the National Cancer Institute. vol.
98, no.24,1767-1776 (2006).
Dallal, Cher M., et al. “Long-term Recreational Physical Activity
and Risk of Invasive and In Situ Breast Cancer: The California Teachers Study.”
Archives of Internal Medicine, vol. 167, no. 4, 408-415 (2007).
Dent, Rebecca, et al. “Triple-Negative Breast Cancer: Clinical
Features and Patterns of Recurrence.” Clinical Cancer Research,
vol. 13, no. 15, 4429-4434 (2007).
Enger, Shelley M., et al. “Body Size, Physical Activity, and
Breast Cancer Hormone Receptor Status: Results from Two Case-Control Studies.” Cancer
Epidemiology, Biomarkers & Prevention,
vol.9, no.7, 681-687 (2000).
Fisher, Bernard, et al. “Twenty-Year Follow-up of a Randomized
Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy Plus Irradiation
for the Treatment of Invasive Breast Cancer.” New England Journal of Medicine,
vol. 347, 1233-1241 (2002).
Sioshansi, et al., “Triple negative breast cancer is associated with an increased risk of
residual invasive carcinoma after lumpectomy,” Cancer, vol. 118, no. 16, 3893–3898 (2012).
Fung, Teresa T., et al. “Dietary patterns, the Alternate
Healthy Eating Index and plasma sex hormone concentrations in postmenopausal
women.” International
Journal of Cancer, vol 121, no. 4, 803-809 (2007).
Liedtke, Cornelia, et al. “Response to Neoadjuvant Therapy and
Long-Term Survival in Patients With Triple-Negative Breast Cancer.” Journal of Clinical Oncology ,
vol. 26, no. 8, 1275-1281 (2008).
Mustian, K. M., et al. “Effect of YOCAS yoga on sleep,
fatigue, and quality of life: A URCC CCOP randomized, controlled clinical trial
among 410 cancer survivors.” Journal of Clinical Oncology,
vol. 28, no. 15s (2010).
Phipps, Amanda I., et al.
“Body size, physical activity, and risk of triple-negative and estrogen
receptor-positive breast cancer.” Cancer Epidemiology, Biomarkers & Prevention,
vol. 20, no. 3, 454-463 (2011).
Pierce, John P., et al. “Influence of a Diet Very High in
Vegetables, Fruit, and Fiber and Low in Fat on Prognosis Following Treatment
for Breast Cancer: The Women's Healthy Eating and Living (WHEL) Randomized
Trial.” JAMA: The Journal of the American Medical
Association, vol.
298, no. 3, 289-298 (2007).
Rauscher, Garth, et.al. “Does psychosocial stress play a role in the
etiology of aggressive breast cancer? A cross-sectional study.” Cancer Epidemiology Biomarkers &
Prevention, Vol. 20, No. 10, Supplement 1
(2011).